HOspital Versus Primary Care Breath Test Environment (HOPE) Study
Launched by IMPERIAL COLLEGE LONDON · Sep 23, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The HOPE study is a clinical trial designed to explore how breath tests, which analyze the gases in your exhaled breath, differ between primary care (like your family doctor) and secondary care (like a hospital). Researchers want to find out if the results of these breath tests are consistent no matter where they are taken, which could help confirm that the tests can be used effectively in everyday medical settings. The study will also look at how stable the results are for the same individual over time.
To participate in the HOPE study, you need to be at least 18 years old and willing to give your consent to take part. Pregnant women are not eligible, but aside from that, there are no other strict requirements, as participants will serve as their own controls. If you decide to join, you can expect to provide breath samples and help researchers understand how these tests might be used in routine healthcare. This study aims to make breath tests a more reliable option for diagnosing health conditions in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Participants will be:
- • Aged ≥ 18 years old
- • Willing and able to provide informed consent to take part in study.
- Exclusion Criteria:
- • Pregnant women will be excluded from this study. With the exception of pregnant women, there are no additional strict exclusion criteria as individuals will act as their own control.
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported